Title :

management of epithelial ovarian cancer. Short text drafted from the french joint recommendations of francogyn, cngof, sfog, gineco-arcagy and endorsed by inca

Author(s) :

Lavoue, Vincent [Auteur]
Huchon, Cyrille [Auteur]
Akladios, Cherif [Auteur]
Alfonsi, Pascal [Auteur]
Bakrin, Naoual [Auteur]
Ballester, Marcos [Auteur]
Bendifallah, Sofiane [Auteur]
Bolze, Pierre-Adrien [Auteur]
Bonnet, Fabrice [Auteur]
Bourgin, Charlotte [Auteur]
Chabbert-Buffet, Nathalie [Auteur]
Collinet, Pierre [Auteur]
Thérapies Lasers Assistées par l'Image pour l'Oncologie (ONCO-THAI) - U1189
Courbiere, Blandine [Auteur]
De La Motte Rouge, Thibault [Auteur]
Devouassoux-Shisheboran, Mojgan [Auteur]
Falandry, Claire [Auteur]
Ferron, Gwenael [Auteur]
Fournier, Laure [Auteur]
Gladieff, Laurence [Auteur]
Golfier, Francois [Auteur]
Gouy, Sebastien [Auteur]
Guyon, Frederique [Auteur]
Lambaudie, Eric [Auteur]
Leary, Alexandra [Auteur]
Lecuru, Fabrice [Auteur]
Lefrere-Belda, Marie-Aude [Auteur]
Leblanc, Eric [Auteur]
Lemoine, Adrien [Auteur]
Narducci, Fabrice [Auteur]
Ouldamer, Lobna [Auteur]
Pautier, Patricia [Auteur]
Planchamp, Francois [Auteur]
Pouget, Nicolas [Auteur]
Ray-Coquard, Isabelle [Auteur]
Rousset-Jablonski, Christine [Auteur]
Senechal-Davin, Claire [Auteur]
Touboul, Cyril [Auteur]
Thomassin-Naggara, Isabelle [Auteur]
Uzan, Catherine [Auteur]
You, Benoit [Auteur]
Darai, Emile [Auteur]

Journal title :

Bulletin du cancer

Abbreviated title :

Bull Cancer

Publication date :

2019-03-05

ISSN :

1769-6917

Keyword(s) :

Guidelines
Surgery
Peritoneal cancer
Fallopian tube cancer
Ovarian cancer
Chemotherapy

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

Faced to an undetermined ovarian mass on ultrasound, an MRI is recommended and the ROMA score (combining CA125 and HE4) can be proposed (grade A). In case of suspected early stage ovarian or fallopian tube cancer, omentectomy ...
Show more >Faced to an undetermined ovarian mass on ultrasound, an MRI is recommended and the ROMA score (combining CA125 and HE4) can be proposed (grade A). In case of suspected early stage ovarian or fallopian tube cancer, omentectomy (at least infracolonic), appendectomy, multiple peritoneal biopsies, peritoneal cytology (grade C) and pelvic and para-aortic lymphadenectomy are recommended (grade B) for all histological types, except for the expansive mucinous subtype where lymphadenectomy may be omitted (grade C). Minimally invasive surgery is recommended for early stage ovarian cancer, if there is no risk of tumor rupture (grade B). Adjuvant chemotherapy with carboplatin and paclitaxel is recommended for all high-grade ovarian or Fallopian tube cancers, stage FIGO I-IIA (grade A). In case of ovarian, Fallopian tube or primitive peritoneal cancer of FIGO III-IV stages, thoraco-abdomino-pelvic CT scan with injection (grade B) is recommended. Laparoscopic exploration for multiple biopsies (grade A) and to evaluate carcinomatosis score (at least using the Fagotti score) (grade C) are recommended to estimate the possibility of a complete surgery (i.e. no macroscopic residue). Complete medial laparotomy surgery is recommended for advanced cancers (grade B). It is recommended in advanced cancers to perform para-aortic and pelvic lymphadenectomy in case of clinical or radiological suspicion of metastatic lymph node (grade B). In the absence of clinical or radiological lymphadenopathy and in case of complete peritoneal surgery during an initial surgery for advanced cancer, it is possible not to perform a lymphadenectomy because it does not modify the medical treatment and the overall survival (grade B). Primary surgery is recommended when no tumor residue is possible (grade B). After a complete first surgery, it is recommended to deliver 6 cycles of intravenous (grade A) or to propose intraperitoneal (grade B) chemotherapy, to be discussed with patient, according to the benefit/risk ratio. After a complete interval surgery for a FIGO III stage, the hyperthermic intra peritoneal chemotherapy (HIPEC) can be proposed in the same conditions of the OV-HIPEC trial (grade B). In case of tumor residue after surgery or FIGO stage IV, chemotherapy associated with bevacizumab is recommended (grade A).Show less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

INSERM
Université de Lille

Collections :

• Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192

Submission date :

2022-06-15T13:58:50Z